Correlation Between Meitav Trade and DNA Biomed

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Meitav Trade and DNA Biomed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Meitav Trade and DNA Biomed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Meitav Trade Inv and DNA Biomed Solns, you can compare the effects of market volatilities on Meitav Trade and DNA Biomed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Meitav Trade with a short position of DNA Biomed. Check out your portfolio center. Please also check ongoing floating volatility patterns of Meitav Trade and DNA Biomed.

Diversification Opportunities for Meitav Trade and DNA Biomed

-0.23
  Correlation Coefficient

Very good diversification

The 3 months correlation between Meitav and DNA is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Meitav Trade Inv and DNA Biomed Solns in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DNA Biomed Solns and Meitav Trade is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Meitav Trade Inv are associated (or correlated) with DNA Biomed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DNA Biomed Solns has no effect on the direction of Meitav Trade i.e., Meitav Trade and DNA Biomed go up and down completely randomly.

Pair Corralation between Meitav Trade and DNA Biomed

Assuming the 90 days trading horizon Meitav Trade Inv is expected to generate 0.38 times more return on investment than DNA Biomed. However, Meitav Trade Inv is 2.63 times less risky than DNA Biomed. It trades about 0.8 of its potential returns per unit of risk. DNA Biomed Solns is currently generating about 0.05 per unit of risk. If you would invest  928.00  in Meitav Trade Inv on August 27, 2024 and sell it today you would earn a total of  171.00  from holding Meitav Trade Inv or generate 18.43% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Meitav Trade Inv  vs.  DNA Biomed Solns

 Performance 
       Timeline  
Meitav Trade Inv 

Risk-Adjusted Performance

39 of 100

 
Weak
 
Strong
Very Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Meitav Trade Inv are ranked lower than 39 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Meitav Trade sustained solid returns over the last few months and may actually be approaching a breakup point.
DNA Biomed Solns 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in DNA Biomed Solns are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, DNA Biomed sustained solid returns over the last few months and may actually be approaching a breakup point.

Meitav Trade and DNA Biomed Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Meitav Trade and DNA Biomed

The main advantage of trading using opposite Meitav Trade and DNA Biomed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Meitav Trade position performs unexpectedly, DNA Biomed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DNA Biomed will offset losses from the drop in DNA Biomed's long position.
The idea behind Meitav Trade Inv and DNA Biomed Solns pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance